ConductScience.org, home
A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)
API referenceFor AI assistants

Trial · NCT00648648

Participant flow112

How many started, completed or left each group, period by period.

1 to 20 of 112

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDMK-1775 325 mg Single Dose3
Overall StudySTARTEDMK-1775 650 mg Single Dose3
Overall StudySTARTEDMK-1775 1300 mg Single Dose3
Overall StudySTARTEDMK-1775 100 mg Single Dose + Gemcitabine 1000 mg/m^24
Overall StudySTARTEDMK-1775 200 mg Single Dose + Gemcitabine 1000 mg/m^29
Overall StudySTARTEDMK-1775 100 mg Single Dose + Cisplatin 75 mg/ m^21
Overall StudySTARTEDMK-1775 200 mg Single Dose + Cisplatin 75 mg/ m^210
Overall StudySTARTEDMK-1775 100 mg Single Dose + Carboplatin AUC 51
Overall StudySTARTEDMK-1775 200 mg Single Dose + Carboplatin AUC 53
Overall StudySTARTEDMK-1775 325 mg Single Dose + Carboplatin AUC 510
Overall StudySTARTEDMK-1775 25 mg BID x2.5 Multi Dose + Gemcitabine 1000 mg/ m^26
Overall StudySTARTEDMK-1775 50/25 mg BID x2.5 Multi + Gemcitabine 1000 mg/ m^213
Overall StudySTARTEDMK-1775 50 mg BID x2.5 Multi + Gemcitabine 1000 mg/ m^26
Overall StudySTARTEDMK-1775 100 mg QD x2 Multi + Gemcitabine 1000 mg/ m^25
Overall StudySTARTEDMK-1775 125 mg QD x2 Multi + Gemcitabine 1000 mg/ m^24
Overall StudySTARTEDMK-1775 150 mg QD x2 Multi + Gemcitabine 1000 mg/ m^211
Overall StudySTARTEDMK-1775 175 mg QD x2 Multi Dose + Gemcitabine 1000 mg/ m^216
Overall StudySTARTEDMK-1775 200 mg QD x2 Multi Dose + Gemcitabine 1000 mg/ m^26
Overall StudySTARTEDMK-1775 50 mg BID x2.5 Multi Dose + Cisplatin 75 mg/ m^25
Overall StudySTARTEDMK-1775 100 mg BID x2.5 Multi Dose + Cisplatin 75 mg/ m^27

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00648648/flow

API referenceFor AI assistants